CATURANO, ALFREDO
 Distribuzione geografica
Continente #
EU - Europa 615
NA - Nord America 603
AS - Asia 146
AF - Africa 4
Totale 1.368
Nazione #
US - Stati Uniti d'America 601
IE - Irlanda 268
IT - Italia 200
SG - Singapore 68
DE - Germania 44
GB - Regno Unito 42
CN - Cina 26
KR - Corea 18
FI - Finlandia 11
FR - Francia 8
IN - India 8
SE - Svezia 8
TR - Turchia 8
IR - Iran 6
BE - Belgio 5
CZ - Repubblica Ceca 4
EG - Egitto 4
ES - Italia 4
GR - Grecia 4
ID - Indonesia 4
CH - Svizzera 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
MO - Macao, regione amministrativa speciale della Cina 2
NL - Olanda 2
RS - Serbia 2
CA - Canada 1
DK - Danimarca 1
GE - Georgia 1
IL - Israele 1
MX - Messico 1
NO - Norvegia 1
QA - Qatar 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
UA - Ucraina 1
Totale 1.368
Città #
Dublin 252
Chandler 145
Naples 73
New York 58
Santa Clara 51
Singapore 45
Cambridge 25
Princeton 25
Roxbury 25
Seoul 17
Bremen 16
Munich 14
Ashburn 11
Beijing 10
Des Moines 9
Caserta 8
Istanbul 8
Milan 8
Liveri 7
Helsinki 6
Napoli 6
Boardman 5
Brussels 5
Houston 5
Lappeenranta 5
Atlanta 4
Brno 4
Casamarciano 4
Damietta 4
Duncan 4
Florence 4
Mumbai 4
Nonantola 4
Nuremberg 4
Andover 3
Boydton 3
Changsha 3
Eboli 3
Jacksonville 3
Medford 3
Nanjing 3
Nola 3
Norwalk 3
Paris 3
Sacramento 3
Wilmington 3
Zanjan 3
Zurich 3
Ann Arbor 2
Antea 2
Avellino 2
Aversa 2
Banda Aceh 2
Belgrade 2
Camden 2
Carinaro 2
Cerro Maggiore 2
Crispano 2
Frankfurt am Main 2
Hanover 2
Laurel 2
Limbiate 2
Los Angeles 2
Macao 2
Malang 2
Monza 2
Piano di Sorrento 2
Rimini 2
Rome 2
San Felice A Cancello 2
San Giovanni In Fiore 2
Saviano 2
Aci Sant'Antonio 1
Acireale 1
Amsterdam 1
Arezzo 1
Buonabitacolo 1
Castellammare di Stabia 1
Cluj-napoca 1
Dehradun 1
Doha 1
Dubai 1
Fairfield 1
Fisciano 1
Groningen 1
Haifa 1
Henderson 1
Heroica Matamoros 1
Kolkata 1
Lusciano 1
Magenta 1
Manchester 1
Mondragone 1
Oslo 1
Ottaviano 1
Ottawa 1
Pensacola 1
Portici 1
Portico di Caserta 1
Salerno 1
Totale 993
Nome #
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 56
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 51
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 50
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 49
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 48
HCC and molecular targeting therapies: Back to the future 45
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 45
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 43
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 43
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 41
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 41
Cardiovascular benefits from gliflozins: Effects on endothelial function 40
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 39
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 39
High HDL Cholesterol: a risk factor for Diabetic Retinopathy? Findings from NO BLIND study 37
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 36
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 36
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 35
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 34
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 34
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 33
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 33
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 31
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 29
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 27
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 26
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 26
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects 25
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 24
Brugada syndrome and COVID-19 vaccines 24
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 24
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 23
Polypharmacy and major adverse events in atrial fibrillation 19
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 19
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 17
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 16
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 15
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 15
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 15
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 14
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 14
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 13
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 13
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 13
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 12
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 11
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 11
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 10
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 9
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 9
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 7
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 7
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 6
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 5
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 5
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 5
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 3
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives 2
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 2
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 2
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 2
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 2
Advances in Nanomedicine for Precision Insulin Delivery 2
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 2
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 2
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 2
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 2
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 1
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 1
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 1
Totale 1.473
Categoria #
all - tutte 10.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 2 0 0 0 0 0
2020/202141 5 1 0 2 1 4 6 4 3 3 5 7
2021/2022226 11 1 8 21 39 8 4 4 11 27 33 59
2022/2023551 32 30 18 21 73 32 5 36 257 11 12 24
2023/2024397 35 17 14 28 86 69 9 10 9 31 35 54
2024/2025250 13 20 14 36 167 0 0 0 0 0 0 0
Totale 1.473